Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr208.00 DKK
Change Today +2.00 / 0.97%
Volume 72.7K
As of 11:04 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

ambu a/s-b (AMBUB) Snapshot

Open
kr205.00
Previous Close
kr206.00
Day High
kr209.50
Day Low
kr202.00
52 Week High
09/1/15 - kr209.50
52 Week Low
10/16/14 - kr90.50
Market Cap
10.0B
Average Volume 10 Days
62.7K
EPS TTM
kr3.59
Shares Outstanding
41.4M
EX-Date
12/18/14
P/E TM
57.9x
Dividend
kr0.94
Dividend Yield
0.45%
Current Stock Chart for AMBU A/S-B (AMBUB)

Related News

No related news articles were found.

ambu a/s-b (AMBUB) Related Businessweek News

No Related Businessweek News Found

ambu a/s-b (AMBUB) Details

Ambu A/S provides healthcare solutions in anesthesia, patient monitoring and diagnostics, and emergency care fields worldwide. The company offers anesthesia products, including laryngeal masks, ventilation bags, face masks for artificial ventilation, scopes for visualization, anesthesia tubes, and pumps for palliative care; patient monitoring and diagnostics products, such as single-use electrodes for neurological and cardiological examinations, and tubes and needles; emergency care products comprising neck collars, manikins, and other equipment for first-aid training; conductive adhesive gels for use in the production of skin-contacting biomedical electrodes; and single-use videoscopes. The company serves hospitals, clinics, rescue services and sleep laboratories, aid organizations, and the armed forces. It sells and exports its products through direct sales and distributors. The company was founded in 1937 and is headquartered in Ballerup, Denmark.

2,350 Employees
Last Reported Date: 08/19/15
Founded in 1937

ambu a/s-b (AMBUB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ambu a/s-b (AMBUB) Key Developments

Ambu A/S Announces Unaudited Earnings Results for the Third Quarter and First Nine Months Ended June 30, 2015; Revises Earnings Guidance for the Full Year Ending September 30, 2015

Ambu A/S announced unaudited earnings results for the third quarter and first nine months ended June 30, 2015. For the quarter, the company announced revenue of DKK 482 million compared to DKK 397 million for the same period a year ago. Operating profit (EBIT) was DKK 56 million compared to DKK 55 million for the same period a year ago. Profit before tax (PBT) was DKK 27 million compared to DKK 45 million for the same period a year ago. Net profit for the period was DKK 20 million compared to DKK 33 million for the same period a year ago. Diluted earnings per share was DKK 0.40 compared to DKK 0.68 for the same period a year ago. Free cash flows before company acquisitions totaled DKK 34 million compared to DKK 28 million for the same period a year ago. Cash flows are materially affected by increased investments, including the new factory in Malaysia, as well as by funds tied up in working capital. Cash flows from operating activities was DKK 57 million compared to DKK 53 million for the same period a year ago. EBITDA was DKK 81 million compared to DKK 78 million for the same period a year ago. Return on equity was 20% compared to 14% for the same period a year ago. For the first nine months, the company announced revenue of DKK 1,353 million compared to DKK 1,142 million for the same period a year ago. Operating profit (EBIT) was DKK 119 million compared to DKK 118 million for the same period a year ago. Profit before tax (PBT) was DKK 115 million compared to DKK 90 million for the same period a year ago. Net profit for the period was DKK 86 million compared to DKK 66 million for the same period a year ago. Diluted earnings per share were DKK 1.75 compared to DKK 1.36 for the same period a year ago. Cash flows from operating activities was DKK 68 million compared to DKK 110 million for the same period a year ago. Purchase of non-current assets was DKK 80 million compared to DKK 53 million for the same period a year ago. Free cash flows used before company acquisitions was DKK 12 million compared to free cash flow generated before acquisitions of DKK 57 million for the same period a year ago. Free cash flows used after company acquisitions was DKK 30 million compared to DKK 51 million for the same period a year ago. Return on equity was 20% compared to 14% for the same period a year ago. EBITDA was DKK 192 million compared to DKK 181 million for the same period a year ago. Net interest-bearing debt at the end of the period was DKK 804 million compared to DKK 784 million for the same period a year ago. The company revised earnings guidance for the full year ending September 30, 2015. For the year, revenue outlook is adjusted and now expects growth in local currencies of approximately 9% as opposed to 8% to 8.5% previously announced. The outlook for the EBIT margin is un-changed at approximately 12%, resulting in an upward adjustment of EBIT in Danish kroner. Free cash flows before earn-out payment of approximately DKK 100 million are now expected as opposed to approximately DKK 110 million to DKK 120 million. A gearing of approximately 2.2 is still expected.

Ambu A/S, Q3 2015 Earnings Call, Aug 19, 2015

Ambu A/S, Q3 2015 Earnings Call, Aug 19, 2015

Ambu Appoints Carsten Buhl as Executive Vice President (Chief Commercial Officer), Effective from August 03, 2015

Ambu appointed Carsten Buhl as Executive Vice President (Chief Commercial Officer). He will be responsible for Ambu's sales and marketing across the organisation in Europe, USA and Asia-Pacific. Carsten Buhl has 13 years of experience from the GN Store Nord corporation with his latest position being Senior Vice President, Europe Sales & Strategic Accounts at GN ReSound. Effective from August 03, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMBUB:DC kr208.00 DKK +2.00

AMBUB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Repro-Med Systems Inc $0.36 USD -0.0268
View Industry Companies
 

Industry Analysis

AMBUB

Industry Average

Valuation AMBUB Industry Range
Price/Earnings 57.3x
Price/Sales 5.4x
Price/Book 10.0x
Price/Cash Flow 48.5x
TEV/Sales 4.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMBU A/S-B, please visit www.ambu.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.